Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.
about
Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.Ongoing developments in sporadic inclusion body myositisThe effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis.APOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D (1)H-MRS in non-demented elders
P2860
Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Polymorphism in the TOMM40 gen ...... the age of onset of symptoms.
@en
Polymorphism in the TOMM40 gen ...... the age of onset of symptoms.
@nl
type
label
Polymorphism in the TOMM40 gen ...... the age of onset of symptoms.
@en
Polymorphism in the TOMM40 gen ...... the age of onset of symptoms.
@nl
prefLabel
Polymorphism in the TOMM40 gen ...... the age of onset of symptoms.
@en
Polymorphism in the TOMM40 gen ...... the age of onset of symptoms.
@nl
P2093
P1476
Polymorphism in the TOMM40 gen ...... the age of onset of symptoms.
@en
P2093
A M Saunders
A Rojana-udomsart
F L Mastaglia
J A Corbett
P304
P356
10.1016/J.NMD.2013.09.008
P577
2013-09-19T00:00:00Z